Contact

EMBL Ventures GmbH
Boxbergring 107
69126 Germany
+49 (0) 6221 389 330
info@embl-ventures.com

"Since their first investment, EMBL Ventures has played a constructive and positive role within Affectis. Providing their extensive network, supporting the company through the board of directors or bringing in new projects, we have developed a fruitful relationship."

Prof. Herbert Stadler; CEO, Affectis Pharmaceuticals, Munich